chr11-94470486-G-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005591.4(MRE11):ā€‹c.1002C>Gā€‹(p.Ser334Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00247 in 1,612,802 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.013 ( 43 hom., cov: 32)
Exomes š‘“: 0.0014 ( 37 hom. )

Consequence

MRE11
NM_005591.4 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 2.01
Variant links:
Genes affected
MRE11 (HGNC:7230): (MRE11 homolog, double strand break repair nuclease) This gene encodes a nuclear protein involved in homologous recombination, telomere length maintenance, and DNA double-strand break repair. By itself, the protein has 3' to 5' exonuclease activity and endonuclease activity. The protein forms a complex with the RAD50 homolog; this complex is required for nonhomologous joining of DNA ends and possesses increased single-stranded DNA endonuclease and 3' to 5' exonuclease activities. In conjunction with a DNA ligase, this protein promotes the joining of noncomplementary ends in vitro using short homologies near the ends of the DNA fragments. This gene has a pseudogene on chromosome 3. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035775304).
BP6
Variant 11-94470486-G-C is Benign according to our data. Variant chr11-94470486-G-C is described in ClinVar as [Benign]. Clinvar id is 140946.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-94470486-G-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0129 (1955/152130) while in subpopulation AFR AF= 0.0443 (1839/41518). AF 95% confidence interval is 0.0426. There are 43 homozygotes in gnomad4. There are 919 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1955 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MRE11NM_005591.4 linkuse as main transcriptc.1002C>G p.Ser334Arg missense_variant 9/20 ENST00000323929.8 NP_005582.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MRE11ENST00000323929.8 linkuse as main transcriptc.1002C>G p.Ser334Arg missense_variant 9/201 NM_005591.4 ENSP00000325863 P3P49959-1
MRE11ENST00000323977.7 linkuse as main transcriptc.1002C>G p.Ser334Arg missense_variant 9/191 ENSP00000326094 P49959-2
MRE11ENST00000407439.7 linkuse as main transcriptc.1011C>G p.Ser337Arg missense_variant 9/202 ENSP00000385614 P49959-3
MRE11ENST00000393241.8 linkuse as main transcriptc.1002C>G p.Ser334Arg missense_variant 9/205 ENSP00000376933 A1

Frequencies

GnomAD3 genomes
AF:
0.0128
AC:
1947
AN:
152012
Hom.:
43
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0442
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00460
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000382
Gnomad OTH
AF:
0.00911
GnomAD3 exomes
AF:
0.00353
AC:
886
AN:
251082
Hom.:
20
AF XY:
0.00242
AC XY:
329
AN XY:
135714
show subpopulations
Gnomad AFR exome
AF:
0.0470
Gnomad AMR exome
AF:
0.00220
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000282
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00139
AC:
2036
AN:
1460672
Hom.:
37
Cov.:
31
AF XY:
0.00120
AC XY:
875
AN XY:
726656
show subpopulations
Gnomad4 AFR exome
AF:
0.0450
Gnomad4 AMR exome
AF:
0.00257
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000128
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000183
Gnomad4 OTH exome
AF:
0.00317
GnomAD4 genome
AF:
0.0129
AC:
1955
AN:
152130
Hom.:
43
Cov.:
32
AF XY:
0.0124
AC XY:
919
AN XY:
74354
show subpopulations
Gnomad4 AFR
AF:
0.0443
Gnomad4 AMR
AF:
0.00459
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000382
Gnomad4 OTH
AF:
0.00901
Alfa
AF:
0.000696
Hom.:
2
Bravo
AF:
0.0146
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.0450
AC:
198
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00413
AC:
502
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Ataxia-telangiectasia-like disorder 1 Benign:4
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingCounsylJun 03, 2016- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 16, 2023- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 06, 2016Variant summary: The MRE11A c.1002C>G variant affects a non-conserved nucleotide, resulting in amino acid change from Ser to Arg. 2/3 in-silico tools predict this variant to be benign (SNPs&GO and Mutation Taster not captured due to low reliability index). This variant was found in 502/120966 control chromosomes (8 homozygotes) at a frequency of 0.0041499, which is about 66 times the maximal expected frequency of a pathogenic MRE11A allele (0.0000625), highly suggesting this variant is benign. In addition, one clinical laboratory classified this variant as benign. Taken together, this variant was classified as benign. -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 31, 2019- -
Benign, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoDec 31, 2019- -
Hereditary cancer-predisposing syndrome Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsNov 21, 2014This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Hereditary breast ovarian cancer syndrome Benign:1
Benign, criteria provided, single submitterclinical testingNational Health Laboratory Service, Universitas Academic Hospital and University of the Free StateApr 19, 2022- -
Ataxia-telangiectasia-like disorder Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
19
DANN
Benign
0.92
DEOGEN2
Benign
0.21
T;.;.;.
Eigen
Benign
-0.13
Eigen_PC
Benign
0.075
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.86
D;D;D;D
MetaRNN
Benign
0.0036
T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.14
N;.;N;.
MutationTaster
Benign
0.89
D;D;D;D
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-1.8
N;N;N;N
REVEL
Benign
0.11
Sift
Benign
0.52
T;T;T;T
Sift4G
Benign
0.17
T;T;T;T
Polyphen
0.18
B;.;B;.
Vest4
0.30
MutPred
0.38
.;Gain of catalytic residue at S337 (P = 0.0638);.;.;
MVP
0.76
MPC
0.099
ClinPred
0.0079
T
GERP RS
4.6
Varity_R
0.24
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs115244417; hg19: chr11-94203652; COSMIC: COSV104651900; COSMIC: COSV104651900; API